13d filings : Live Updates Every Minute from 25K+ News Agencies Across the Globe
W.R. Grace, GameStop See Activist Action
W.R. Grace (GRA)
40 North Management revealed a 14.9% interest in W.R. Grace, equal to 9,865,008 shares of the maker of specialty chemicals. On Nov. 9, 40 North offered to take W.R. Grace private for $60.00 cash per share. That offer was rejected by W.R. Grace’s board, and prompted 40 North to raise its bid to $65.00 per...
Close
From
W.R. Grace (GRA)
40 North Management revealed a 14.9% interest in W.R. Grace, equal to 9,865,008 shares of the maker of specialty chemicals. On Nov. 9, 40 North offered to take W.R. Grace private for $60.00 cash per share. That offer was rejected by W.R. Grace’s board, and prompted 40 North to raise its bid to $65.00 per...
Close
From
Herbalife, Tribune Publishing See Activist Action
Tribune Publishing (TPCO)
Alden Global Capital disclosed that it wants to take the media firm private through a proposed offer of $14.25 per share. Alden is currently the largest Tribune Publishing shareholder, with a 31.6% interest, equal to 11,554,306 common shares. Alden’s proposal is nonbinding, and Alden has “not proposed...
Close
From
Tribune Publishing (TPCO)
Alden Global Capital disclosed that it wants to take the media firm private through a proposed offer of $14.25 per share. Alden is currently the largest Tribune Publishing shareholder, with a 31.6% interest, equal to 11,554,306 common shares. Alden’s proposal is nonbinding, and Alden has “not proposed...
Close
From
Evolent Health and FireEye See Activist Action
Engaged Capital initiated a 9.96% position in the health-care, administrative-services tech firm, equal to 8,553,155 Evolent Health shares. That position has remained unchanged, as noted by Engaged Capital’s latest disclosure. What has changed is that Engaged and Evolent entered into a cooperation agreement as of Dec. 21. Per the agreement, Evolent will increase the size of its board by one to accommodate the appointment of an Engaged representative to serve until at least next year’s annual shareholders meeting. Engaged Capital will abide by customary standstill agreements, and will limit its Evolent Health interest to no more than 12%.
Original Filings
Blackstone Group (BX) revealed a fresh position in the cybersecurity firm of 21,449,275 shares. All of the FireEye shares owned by Blackstone underlie preferred convertible securities, including 370,000 shares that underlie a 4.5% convertible preferred series offered through a private placement that closed on Dec. 11. With the latest investment, Blackstone has an 8.5% interest in FireEye. Two Blackstone directors currently serve on FireEye’s board.
Engaged Capital initiated a 9.96% position in the health-care, administrative-services tech firm, equal to 8,553,155 Evolent Health shares. That position has remained unchanged, as noted by Engaged Capital’s latest disclosure. What has changed is that Engaged and Evolent entered into a cooperation agreement as of Dec. 21. Per the agreement, Evolent will increase the size of its board by one to accommodate the appointment of an Engaged representative to serve until at least next year’s annual shareholders meeting. Engaged Capital will abide by customary standstill agreements, and will limit its Evolent Health interest to no more than 12%.
Original Filings
Blackstone Group (BX) revealed a fresh position in the cybersecurity firm of 21,449,275 shares. All of the FireEye shares owned by Blackstone underlie preferred convertible securities, including 370,000 shares that underlie a 4.5% convertible preferred series offered through a private placement that closed on Dec. 11. With the latest investment, Blackstone has an 8.5% interest in FireEye. Two Blackstone directors currently serve on FireEye’s board.
13D filings by Argo Group, Tivity Health and Others
Voce Capital disclosed on Dec. 23 that it held 1,990,676 shares of the property and casualty insurer, equal to a 5.8% interest in the firm. On Dec. 20, Voce submitted a requisition notice on behalf of shareholders holding more than 10% of Argo’s outstanding stock that requires Argo to hold a special meeting within 60 calendar days from the date of the notice. The meeting is to vote for the removal and replacement of five director’s of Argo’s board with an equal number of Voce nominees submitted to Argo through a separate letter.
Increases in Holdings
Hudson Executive Capital disclosed on Dec. 19 that it lifted its interest in the fitness and lifestyle firm of 2,728,655 shares, equal to 5.7% of the outstanding stock. Hudson Executive, having cited Tivity Health as “undervalued and an attractive investment,” bought 349,095 shares from Nov. 13 to Dec. 19 at prices of $17.69 to $20.31 apiece. Hudson has had “constructive” discussions with Tivity and expects to further engage the firm regarding a range of operational and strategic topics.
Voce Capital disclosed on Dec. 23 that it held 1,990,676 shares of the property and casualty insurer, equal to a 5.8% interest in the firm. On Dec. 20, Voce submitted a requisition notice on behalf of shareholders holding more than 10% of Argo’s outstanding stock that requires Argo to hold a special meeting within 60 calendar days from the date of the notice. The meeting is to vote for the removal and replacement of five director’s of Argo’s board with an equal number of Voce nominees submitted to Argo through a separate letter.
Increases in Holdings
Hudson Executive Capital disclosed on Dec. 19 that it lifted its interest in the fitness and lifestyle firm of 2,728,655 shares, equal to 5.7% of the outstanding stock. Hudson Executive, having cited Tivity Health as “undervalued and an attractive investment,” bought 349,095 shares from Nov. 13 to Dec. 19 at prices of $17.69 to $20.31 apiece. Hudson has had “constructive” discussions with Tivity and expects to further engage the firm regarding a range of operational and strategic topics.
Resideo, Rocket Pharma, GTT, and 8 Other 13D Filings
Dec. 20, 2019 8:15 pm ET
Order Reprints
Text size
13Ds are filed with the Securities and Exchange Commission within 10 days of an entity’s attaining a greater than 5% position in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material has been extracted from filings released by the SEC from Dec. 12 through Dec. 18, 2019.
Source: InsiderScore.com
Resideo Technologies (REZI)
Praesidium Investment Management reported an increased position in the safety-controls and electronics manufacturer of 7,781,233 shares, equal to 6.3% of the tradable stock. The larger holding resulted from the purchase of 1,678,355 shares at prices of $9.91 to $11.04 each from Dec. 3 to Dec. 11. Praesidium cited that it has faith in Resideo’s products and solutions unit’s “strong competitive position in the pro-contractor channel,” and that the firm’s ADI Global Distribution is “dramatically underappreciated” given the current mergers-and-acquisitions environment and the division’s “leading position and demonstrated track record of strong execution.” Praesidium cited that the recent changes to Resideo’s board, including the search for a new CEO, represent a “decisive step forward’’ to operational improvement, and revealed that it will likely continue to engage Resideo “to drive growth, profitability and free cash flow, and total shareholder returns.”
Dec. 20, 2019 8:15 pm ET
Order Reprints
Text size
13Ds are filed with the Securities and Exchange Commission within 10 days of an entity’s attaining a greater than 5% position in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material has been extracted from filings released by the SEC from Dec. 12 through Dec. 18, 2019.
Source: InsiderScore.com
Resideo Technologies (REZI)
Praesidium Investment Management reported an increased position in the safety-controls and electronics manufacturer of 7,781,233 shares, equal to 6.3% of the tradable stock. The larger holding resulted from the purchase of 1,678,355 shares at prices of $9.91 to $11.04 each from Dec. 3 to Dec. 11. Praesidium cited that it has faith in Resideo’s products and solutions unit’s “strong competitive position in the pro-contractor channel,” and that the firm’s ADI Global Distribution is “dramatically underappreciated” given the current mergers-and-acquisitions environment and the division’s “leading position and demonstrated track record of strong execution.” Praesidium cited that the recent changes to Resideo’s board, including the search for a new CEO, represent a “decisive step forward’’ to operational improvement, and revealed that it will likely continue to engage Resideo “to drive growth, profitability and free cash flow, and total shareholder returns.”
Primo Water, Verso, Arch Coal and Other 13D Filings
Primo Water, Verso, Arch Coal and Other 13D Filings
Published: Nov. 1, 2019 at 8:30 p.m. ET
By
13Ds are filed with the Securities and Exchange Commission within 10 days of an entity’s attaining a greater than 5% position in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material has been extracted from filings released by the SEC from Oct. 24 through Oct. 30, 2019.
Source: InsiderScore.com
PRMW)
Legion Partners Asset Management revealed on Oct. 28 that it had 3,567,946 shares of the purified water retailer—9.1% of the outstanding stock.
On Oct. 29, Legion Partners issued a press release, declaring “continued frustration” with what it termed Primo’s unwillingness to engage with it, despite “attempts to work constructively with [Primo] over the past 19 months.”
Primo Water, Verso, Arch Coal and Other 13D Filings
Published: Nov. 1, 2019 at 8:30 p.m. ET
By
13Ds are filed with the Securities and Exchange Commission within 10 days of an entity’s attaining a greater than 5% position in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material has been extracted from filings released by the SEC from Oct. 24 through Oct. 30, 2019.
Source: InsiderScore.com
PRMW)
Legion Partners Asset Management revealed on Oct. 28 that it had 3,567,946 shares of the purified water retailer—9.1% of the outstanding stock.
On Oct. 29, Legion Partners issued a press release, declaring “continued frustration” with what it termed Primo’s unwillingness to engage with it, despite “attempts to work constructively with [Primo] over the past 19 months.”